Dako's new Board and Management in place
Dako's new board is now in place and a new Corporate Vice President, Operations, has been appointed as member of the Corporate Management. Two new board members entered Dako's Board of Directors as of 28 August:
- Staffan Ek, former Head of Roches' Diabetes Care business area and former member of the executive committee of Roche Diagnostics GmbH. Currently a member of the board of Axis-Schield plc and Facet Technologies LLC.
- Charles M. Fleischmann, former president of Digene Corporation (now Qiagen) and member of the board of The Institute for Health Technology Studies (InHealth).
The new board begins work in a recently restructured Dako, which is now ready with a new business model and production strategy.
Corporate management has been strengthened with the appointment of Jorge A. Cerda, who starts as new Corporate Vice President, Operations, as of 1 November. Jorge A. Cerda comes from a position as President of GE Healthcare AB. Jorge Cerda has more than 20 years experience within biotech production based on clear customer focus, optimizing production methods and efficient production planning.
Members of Dako's new board are: Mats Fischier (Chairman), Ole Andersen (Senior Partner, EQT Partner A/S) , Morten Hummelmose (Director, EQT Partners A/S), Søren Mellstig (former President of Gambro AB), Staffan Ek (former Head of Business Area Diabetes Care within Roche Diagnostics Division), and Charles M. Fleischmann (former President of Digene Corporation (now Qiagen)).
Members of Dako's future corporate management are: Patrik Dahlén (CEO, President), Leif Nørgaard (CFO, Executive Vice President, Finance); Sarah Taylor (Corporate Vice President, People & Organization), Per Sjøberg (Corporate Vice President, Sales), Mats Grahn (Corporate Vice President, Marketing), Rolf Ehrnstrøm (Corporate Vice President, Research & Development), Jorge A. Cerda Lucero (new Corporate Vice President, Production, as of 1. November 2007).
Most read news
Other news from the department people
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
PANalytical announced the opening of its new Regional Application Laboratory in Shanghai, China
Henry Ford's idea revisited in DNA copying
First view of hydrogen at the metal-to-metal hydride interface
Waters Corporation to Assist US EPA in the Analysis of Perfluorinated Compounds (PFCs) in Soil and Water - Latest CRADA Aimed at Developing Liquid Chromatography and Mass Spectrometry Methods for Measuring PFCs at Very Low Concentrations
ZEISS: High-Tech Drives Growth - Medical technology and industrial metrology business still on track for growth
Thermo Fisher Scientific Selected by China Doping Control Center to Supply Testing Instrumentation for the 2008 Olympic Games
Grace extends reach in China
Mapping nanoscale chemical reactions inside batteries in 3-D
Virtual human in HIV drug simulation
No excess baggage: Antarctic insect's genome, newly sequenced, is smallest to date - Researchers suggest bare-bones genome is adaptation to deep freeze